Articles liés à CNS Clinical Trials: Suicidality and Data Collection...

CNS Clinical Trials: Suicidality and Data Collection Workshop Summary - Couverture souple

Institute Of Medicine; Board On Health Sciences Policy; Forum On Neuroscience And Nervous System Disorders

 
9780309148832: CNS Clinical Trials: Suicidality and Data Collection Workshop Summary

Synopsis

The Food and Drug Administration (FDA) now requires that all clinical trials for drugs that affect the central nervous system--including psychiatric drugs--are assessed for whether that drug might cause suicidal ideation or behavior. The Institute of Medicine's (IOM) Forum on Neuroscience and Nervous System Disorders hosted a meeting on June 26, 2009, to discuss the FDA's new policy and how to analyze best whether suicidal thoughts predict actual suicidal behavior in the near future.

Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.